{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:08:29Z","timestamp":1790201309623,"version":"4.1.0"},"reference-count":205,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"vor","delay-in-days":364,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2018]]},"DOI":"10.6061\/clinics\/2018\/e473s","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T09:51:58Z","timestamp":1539683518000},"page":"e473s","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"S1","title":["The human adrenal cortex: growth control and disorders"],"prefix":"10.1016","volume":"73","author":[{"given":"Claudimara Ferini Pacicco","family":"Lotfi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Lucas","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"dos Santos Passaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isadora Pontes","family":"Cavalcante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1-2","key":"10.6061\/clinics\/2018\/e473s_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0925-4773(99)00123-9","article-title":"Expression of steroidogenic factor 1 and Wilms\u2019 tumour 1 during early human gonadal development and sex determination","volume":"87","author":"Hanley","year":"1999","journal-title":"Mech Dev"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0012-1606(74)90291-7","article-title":"Experimental analysis of the migration and differentiation of neuroblasts of the autonomic nervous system and of neurectodermal mesenchymal derivatives, using a biological cell marking technique","volume":"41","author":"Le Douarin","year":"1974","journal-title":"Dev Biol"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/s-2007-978976","article-title":"17 alpha-Hydroxylase and chromogranin A in 6th week human fetal adrenals","volume":"29","author":"Ehrhart-Bornstein","year":"1997","journal-title":"Horm Metab Res"},{"issue":"4","key":"10.6061\/clinics\/2018\/e473s_bib4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/jmor.1051260408","article-title":"Development of zonular patterns in the human adrenal gland","volume":"126","author":"Sucheston","year":"1968","journal-title":"J Morphol"},{"issue":"4","key":"10.6061\/clinics\/2018\/e473s_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0092-8674(94)90211-9","article-title":"A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation","volume":"77","author":"Luo","year":"1994","journal-title":"Cell"},{"key":"10.6061\/clinics\/2018\/e473s_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000321213","article-title":"Role of DAX-1 (NR0B1) and steroidogenic factor-1 (NR5A1) in human adrenal function","volume":"20","author":"El-Khairi","year":"2011","journal-title":"Endocr Dev"},{"issue":"12","key":"10.6061\/clinics\/2018\/e473s_bib7","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1210\/me.2007-0120","article-title":"Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer","volume":"21","author":"Doghman","year":"2007","journal-title":"Mol Endocrinol"},{"issue":"11","key":"10.6061\/clinics\/2018\/e473s_bib8","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1128\/MCB.00222-06","article-title":"Two-step regulation of Ad4BP\/SF-1 gene transcription during fetal adrenal development: initiation by a Hox-Pbx1-Prep1 complex and maintenance via autoregulation by Ad4BP\/SF-1","volume":"26","author":"Zubair","year":"2006","journal-title":"Mol Cell Biol"},{"issue":"23","key":"10.6061\/clinics\/2018\/e473s_bib9","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1128\/MCB.00900-08","article-title":"Developmental links between the fetal and adult zones of the adrenal cortex revealed by lineage tracing","volume":"28","author":"Zubair","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib10","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/MCB.17.3.1476","article-title":"DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita","volume":"17","author":"Ito","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"47","key":"10.6061\/clinics\/2018\/e473s_bib11","doi-asserted-by":"crossref","first-page":"18390","DOI":"10.1073\/pnas.0808936105","article-title":"The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1","volume":"105","author":"Sablin","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.6061\/clinics\/2018\/e473s_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/3822","article-title":"Role of Ahch in gonadal development and gametogenesis","volume":"20","author":"Yu","year":"1998","journal-title":"Nat Genet"},{"issue":"9","key":"10.6061\/clinics\/2018\/e473s_bib13","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1210\/en.2010-0986","article-title":"Evidence of adrenal failure in aging Dax1-deficient mice","volume":"152","author":"Scheys","year":"2011","journal-title":"Endocrinology"},{"issue":"8","key":"10.6061\/clinics\/2018\/e473s_bib14","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1210\/me.2003-0159","article-title":"DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation","volume":"17","author":"Lalli","year":"2003","journal-title":"Mol Endocrinol"},{"issue":"2","key":"10.6061\/clinics\/2018\/e473s_bib15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ecl.2015.02.001","article-title":"Development of adrenal cortex zonation","volume":"44","author":"Xing","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"20","key":"10.6061\/clinics\/2018\/e473s_bib16","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1242\/dev.150516","article-title":"Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1","volume":"144","author":"Xing","year":"2017","journal-title":"Development"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/edrv-11-1-151","article-title":"Regulation of the primate fetal adrenal cortex","volume":"11","author":"Pepe","year":"1990","journal-title":"Endocr Rev"},{"issue":"47","key":"10.6061\/clinics\/2018\/e473s_bib18","doi-asserted-by":"crossref","first-page":"29886","DOI":"10.1074\/jbc.272.47.29886","article-title":"Unmasking a growth promoting effect of the adrenocorticotropic hormone in Y1 mouse adrenocortical tumor cells","volume":"272","author":"Lotfi","year":"1997","journal-title":"J Biol Chem"},{"issue":"9","key":"10.6061\/clinics\/2018\/e473s_bib19","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1210\/jcem.86.9.7849","article-title":"Expression and coupling characteristics of the CRH and orexin type 2 receptors in human fetal adrenals","volume":"86","author":"Karteris","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/jc.2004-0865","article-title":"Corticotropin releasing hormone directly stimulates cortisol and the cortisol biosynthetic pathway in human fetal adrenal cells","volume":"90","author":"Sirianni","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.6061\/clinics\/2018\/e473s_bib21","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1210\/endo.137.10.8828511","article-title":"Functional maturation of the primate fetal adrenal in vivo: I. Role of insulin-like growth factors (IGFs), IGF-I receptor, and IGF binding proteins in growth regulation","volume":"137","author":"Coulter","year":"1996","journal-title":"Endocrinology"},{"issue":"1-2","key":"10.6061\/clinics\/2018\/e473s_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1076\/apab.110.1.99.894","article-title":"Role of pituitary POMC-peptides and insulin-like growth factor II in the developmental biology of the adrenal gland","volume":"110","author":"Coulter","year":"2002","journal-title":"Arch Physiol Biochem"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003160","article-title":"Insulin and IGF1 receptors are essential for XX and XY gonadal differentiation and adrenal development in mice","volume":"9","author":"Pitetti","year":"2013","journal-title":"PLoS Genet"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.devcel.2013.09.003","article-title":"WT1 maintains adrenal-gonadal primordium identity and marks a population of AGP-like progenitors within the adrenal gland","volume":"27","author":"Bandiera","year":"2013","journal-title":"Dev Cell"},{"issue":"6-7","key":"10.6061\/clinics\/2018\/e473s_bib25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-2007-978908","article-title":"Hormonally regulated components of the adrenocortical cell environment and the control of adrenal cortex homeostasis","volume":"30","author":"Feige","year":"1998","journal-title":"Horm Metab Res"},{"issue":"5","key":"10.6061\/clinics\/2018\/e473s_bib26","first-page":"2090","article-title":"Identification of extracellular matrix components and their integrin receptors in the human fetal adrenal gland","volume":"86","author":"Chamoux","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.6061\/clinics\/2018\/e473s_bib27","first-page":"4722","article-title":"Involvement of the angiotensin II type 2 receptor in apoptosis during human fetal adrenal gland development","volume":"84","author":"Chamoux","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.6061\/clinics\/2018\/e473s_bib28","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1590\/S0100-879X2005001000006","article-title":"A connection between extracellular matrix and hormonal signals during the development of the human fetal adrenal gland","volume":"38","author":"Chamoux","year":"2005","journal-title":"Braz J Med Biol Res"},{"issue":"10","key":"10.6061\/clinics\/2018\/e473s_bib29","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1210\/me.2009-0055","article-title":"Transgenic expression of Ad4BP\/SF 1 in fetal adrenal progenitor cells leads to ectopic adrenal formation","volume":"23","author":"Zubair","year":"2009","journal-title":"Mol Endocrinol"},{"issue":"50","key":"10.6061\/clinics\/2018\/e473s_bib30","doi-asserted-by":"crossref","first-page":"21185","DOI":"10.1073\/pnas.0909471106","article-title":"Shh signaling regulates adrenocortical development and identifies progenitors of steroidogenic lineages","volume":"106","author":"King","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"10.6061\/clinics\/2018\/e473s_bib31","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1242\/dev.092775","article-title":"Fetal adrenal capsular cells serve as progenitor cells for steroidogenic and stromal adrenocortical cell lineages in M. musculus","volume":"140","author":"Wood","year":"2013","journal-title":"Development"},{"issue":"1-2","key":"10.6061\/clinics\/2018\/e473s_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0925-4773(01)00298-2","article-title":"Pod-1\/Capsulin shows a sex- and stage-dependent expression pattern in the mouse gonad development and represses expression of Ad4BP\/SF-1","volume":"102","author":"Tamura","year":"2001","journal-title":"Mech Dev"},{"issue":"1-2","key":"10.6061\/clinics\/2018\/e473s_bib33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.mce.2012.12.029","article-title":"POD-1 binding to the E-box sequence inhibits SF-1 and StAR expression in human adrenocortical tumor cells","volume":"371","author":"Fran\u00e7a","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib34","first-page":"1110","article-title":"Proliferation and apoptosis in the human adrenal cortex during the fetal and perinatal periods: implications for growth and remodeling","volume":"84","author":"Spencer","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1210\/er.2010-0001","article-title":"Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit","volume":"32","author":"Ishimoto","year":"2011","journal-title":"Endocr Rev"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1210\/jc.2005-2720","article-title":"Parturition itself is the basis for fetal adrenal involution","volume":"92","author":"Ben-David","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2018\/e473s_bib37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000321209","article-title":"The physiology and biochemistry of adrenarche","volume":"20","author":"Auchus","year":"2011","journal-title":"Endocr Dev"},{"issue":"2","key":"10.6061\/clinics\/2018\/e473s_bib38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/JOE-12-0022","article-title":"Adrenarche: a cell biological perspective","volume":"214","author":"Hornsby","year":"2012","journal-title":"J Endocrinol"},{"issue":"1-2","key":"10.6061\/clinics\/2018\/e473s_bib39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.mce.2010.11.026","article-title":"The fetal and adult adrenal cortex","volume":"336","author":"Morohashi","year":"2011","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"10.6061\/clinics\/2018\/e473s_bib40","first-page":"1323","article-title":"Normal and pathologic anatomy of the adrenal gland of the mouse, including neoplasms","volume":"44","author":"Dunn","year":"1970","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.6061\/clinics\/2018\/e473s_bib41","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1210\/endo.136.11.7588219","article-title":"Developmentally regulated expression of adrenal 17\u03b1-hydroxylase cytochrome P450 in the mouse embryo","volume":"136","author":"Keeney","year":"1995","journal-title":"Endocrinology"},{"issue":"5","key":"10.6061\/clinics\/2018\/e473s_bib42","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1210\/jc.2009-2010","article-title":"Adrenocortical zonation in humans under normal and pathological conditions","volume":"95","author":"Nishimoto","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"Pt 2","key":"10.6061\/clinics\/2018\/e473s_bib43","first-page":"265","article-title":"The innervation of the mammalian adrenal gland","volume":"183","author":"Parker","year":"1993","journal-title":"J Anat"},{"key":"10.6061\/clinics\/2018\/e473s_bib44","first-page":"33","article-title":"The innervation of the adrenal gland. I. The source of pre- and postganglionic nerve fibres to the rat adrenal gland","volume":"157","author":"Kesse","year":"1988","journal-title":"J Anat"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib45","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1210\/edrv-3-3-299","article-title":"The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands","volume":"3","author":"Gwynne","year":"1982","journal-title":"Endocr Rev"},{"issue":"14","key":"10.6061\/clinics\/2018\/e473s_bib46","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1016\/S0021-9258(17)40133-5","article-title":"Receptor-mediated uptake of low density lipoprotein and utilization of its cholesterol for steroid synthesis in cultured mouse adrenal cells","volume":"252","author":"Faust","year":"1977","journal-title":"J Biol Chem"},{"issue":"47","key":"10.6061\/clinics\/2018\/e473s_bib47","first-page":"5916","article-title":"Scavenger receptor BI: a multi-purpose player in cholesterol and steroid metabolism","volume":"16","author":"Hoekstra","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"1-2","key":"10.6061\/clinics\/2018\/e473s_bib48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0303-7207(99)00051-9","article-title":"Adrenal zonation: clues from 11beta-hydroxylase and aldosterone synthase","volume":"151","author":"Rainey","year":"1999","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"10.6061\/clinics\/2018\/e473s_bib49","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jcem-67-6-1122","article-title":"Muscle and adipose tissue morphology and metabolism in Cushing\u2019s syndrome","volume":"67","author":"Rebuff\u00e9-Scrive","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/edrv-9-1-135","article-title":"Regulation of proopiomelanocortin gene expression in pituitary","volume":"9","author":"Lundblad","year":"1988","journal-title":"Endocr Rev"},{"issue":"4","key":"10.6061\/clinics\/2018\/e473s_bib51","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/j.2040-4603.2014.tb00590.x","article-title":"Adrenal androgens and androgen precursors-definition, synthesis, regulation and physiologic actions","volume":"4","author":"Turcu","year":"2014","journal-title":"Compr Physiol"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/frne.2001.0216","article-title":"DHEA and its transformation intoandrogens and estrogens in peripheral target tissues: intracrinology","volume":"22","author":"Labrie","year":"2001","journal-title":"Front Neuroendocrinol"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib53","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2012-2912","article-title":"Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation","volume":"98","author":"Rege","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.6061\/clinics\/2018\/e473s_bib54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2010.05.012","article-title":"Human adrenal LH\/hCG receptors and what they could mean for adrenal physiology and pathology","volume":"329","author":"Rao","year":"2010","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib55","first-page":"11","article-title":"Cell proliferation and apoptosis in normal and pathologic human adrenal","volume":"8","author":"Sasano","year":"1995","journal-title":"Mod Pathol"},{"issue":"12","key":"10.6061\/clinics\/2018\/e473s_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081865","article-title":"Cell proliferation, movement and differentiation during maintenance of the adult mouse adrenal cortex","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.6061\/clinics\/2018\/e473s_bib57","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2183\/pjab.90.163","article-title":"Functional zonation of the rat adrenal cortex: the development and maintenance","volume":"90","author":"Mitani","year":"2014","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib58","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1210\/en.2009-0814","article-title":"Progenitor cell expansion and organ size of mouse adrenal is regulated by sonic hedgehog","volume":"151","author":"Huang","year":"2010","journal-title":"Endocrinology"},{"issue":"11","key":"10.6061\/clinics\/2018\/e473s_bib59","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1210\/en.2017-00098","article-title":"Targeted Disruption of YAP and TAZ Impairs the Maintenance of the Adrenal Cortex","volume":"158","author":"Levasseur","year":"2017","journal-title":"Endocrinology"},{"issue":"15","key":"10.6061\/clinics\/2018\/e473s_bib60","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1242\/dev.021493","article-title":"Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex","volume":"135","author":"Kim","year":"2008","journal-title":"Development"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mce.2011.09.009","article-title":"Wnt\/\u03b2-catenin signalling in adrenal physiology and tumour development","volume":"351","author":"Berthon","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.6061\/clinics\/2018\/e473s_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/srep19546","article-title":"Activating mutations in CTNNB1 in aldosterone producing adenomas","volume":"6","author":"\u00c5kerstr\u00f6m","year":"2016","journal-title":"Sci Rep"},{"issue":"9","key":"10.6061\/clinics\/2018\/e473s_bib63","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/12506","article-title":"Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin","volume":"5","author":"Yaswen","year":"1999","journal-title":"Nat Med"},{"issue":"10","key":"10.6061\/clinics\/2018\/e473s_bib64","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1210\/en.2004-0491","article-title":"The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin","volume":"145","author":"Coll","year":"2004","journal-title":"Endocrinology"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0016-6480(82)90156-3","article-title":"Immunohistochemical demonstration of pro-gamma-MSH-like substances in the pituitary gland of various vertebrate species","volume":"46","author":"Estivariz","year":"1982","journal-title":"Gen Comp Endocrinol"},{"issue":"2","key":"10.6061\/clinics\/2018\/e473s_bib66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1677\/joe.0.1160207","article-title":"Adrenal regeneration in the rat is mediated by mitogenic N-terminal pro-opiomelanocortin peptides generated by changes in precursor processing in the anterior pituitary","volume":"116","author":"Estivariz","year":"1988","journal-title":"J Endocrinol"},{"issue":"11","key":"10.6061\/clinics\/2018\/e473s_bib67","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/BF01114817","article-title":"Purification and characterization of amino-terminal pro-opiocortin peptides from human pituitary glands","volume":"1","author":"McLean","year":"1981","journal-title":"Biosci Rep"},{"issue":"5938","key":"10.6061\/clinics\/2018\/e473s_bib68","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/306070a0","article-title":"Pro-gamma-melanocyte stimulating hormone cleavage in adrenal gland undergoing compensatory growth","volume":"306","author":"Lowry","year":"1983","journal-title":"Nature"},{"issue":"2","key":"10.6061\/clinics\/2018\/e473s_bib69","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00441-010-0998-0","article-title":"Synthetic modified N-POMC(1-28) controls in vivo proliferation and blocks apoptosis in rat adrenal cortex","volume":"341","author":"Torres","year":"2010","journal-title":"Cell Tissue Res"},{"issue":"1-2","key":"10.6061\/clinics\/2018\/e473s_bib70","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.mce.2010.12.012","article-title":"The proliferative effect of synthetic N-POMC(1-28) peptides in rat adrenal cortex: a possible role for cyclin E","volume":"336","author":"Mendon\u00e7a","year":"2011","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"10.6061\/clinics\/2018\/e473s_bib71","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2002-021318","article-title":"N-terminal proopiomelanocortin acts as a mitogen in adrenocortical tumor cells and decreases adrenal steroidogenesis","volume":"88","author":"Fassnacht","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib72","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00441-011-1220-8","article-title":"Comparative effect of FGF2, synthetic peptides 1-28 N-POMC and ACTH on proliferation in rat adrenal cell primary cultures","volume":"345","author":"Mattos","year":"2011","journal-title":"Cell Tissue Res"},{"issue":"1-2","key":"10.6061\/clinics\/2018\/e473s_bib73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mce.2008.09.021","article-title":"The stimulation of mitogenic signaling pathways by N-POMC peptides","volume":"300","author":"Pepper","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"10.6061\/clinics\/2018\/e473s_bib74","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1210\/endo.141.6.7499","article-title":"Infusion of N proopiomelanocortin (1-77) increases adrenal weight and messenger ribonucleic acid levels of cytochrome P450 17alpha-hydroxylase in the sheep fetus during late gestation","volume":"141","author":"Ross","year":"2000","journal-title":"Endocrinology"},{"issue":"4","key":"10.6061\/clinics\/2018\/e473s_bib75","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1081\/ERC-120016971","article-title":"Adrenal growth is controlled by expression of specific pro-opiomelanocortin serine protease in the outer adrenal cortex","volume":"28","author":"Bicknell","year":"2002","journal-title":"Endocr Res"},{"issue":"9","key":"10.6061\/clinics\/2018\/e473s_bib76","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1210\/en.2004-0179","article-title":"Dual hormonal regulation of endocrine tissue mass and vasculature by adrenocorticotropin in the adrenal cortex","volume":"145","author":"Thomas","year":"2004","journal-title":"Endocrinology"},{"issue":"4","key":"10.6061\/clinics\/2018\/e473s_bib77","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3109\/07435800009048606","article-title":"Neurotransmitters and neuropeptides in the differential regulation of steroidogenesis in adrenocortical-chromaffin co-cultures","volume":"26","author":"Ehrhart-Bornstein","year":"2000","journal-title":"Endocr Res"},{"issue":"9","key":"10.6061\/clinics\/2018\/e473s_bib78","doi-asserted-by":"crossref","first-page":"E104","DOI":"10.1210\/jc.2009-2408","article-title":"Seven novel DAX1 mutations with loss of function identified in Chinese patients with congenital adrenal hypoplasia","volume":"95","author":"Li","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.6061\/clinics\/2018\/e473s_bib79","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/9629","article-title":"A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans","volume":"22","author":"Achermann","year":"1999","journal-title":"Nat Genet"},{"issue":"7","key":"10.6061\/clinics\/2018\/e473s_bib80","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/ng.2275","article-title":"Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome","volume":"44","author":"Arboleda","year":"2012","journal-title":"Nat Genet"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib81","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ajhg.2007.08.005","article-title":"SERKAL syndrome: an autosomal-recessive disorder caused by a loss-of-function mutation in WNT4","volume":"82","author":"Mandel","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.6061\/clinics\/2018\/e473s_bib82","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.beem.2006.09.002","article-title":"The genetics of ACTH resistance syndromes","volume":"20","author":"Metherell","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"12","key":"10.6061\/clinics\/2018\/e473s_bib83","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ejmg.2015.11.001","article-title":"A novel homozygous insertion and review of published mutations in the NNT gene causing familial glucocorticoid deficiency (FGD)","volume":"58","author":"Jazayeri","year":"2015","journal-title":"Eur J Med Genet"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib84","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1172\/JCI60224","article-title":"MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans","volume":"122","author":"Hughes","year":"2012","journal-title":"J Clin Invest"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib85","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MED.0b013e32834ed639","article-title":"Genetic disorders of the pituitary","volume":"19","author":"Cohen","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"8","key":"10.6061\/clinics\/2018\/e473s_bib86","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJMra021561","article-title":"Congenital adrenal hyperplasia","volume":"349","author":"Speiser","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.6061\/clinics\/2018\/e473s_bib87","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1073\/pnas.82.2.521","article-title":"Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man","volume":"82","author":"Carroll","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib88","first-page":"245","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"21","author":"White","year":"2000","journal-title":"Endocr Rev"},{"issue":"4","key":"10.6061\/clinics\/2018\/e473s_bib89","first-page":"421","article-title":"Disorders of steroid 11 beta-hydroxylase isozymes","volume":"15","author":"White","year":"1994","journal-title":"Endocr Rev"},{"issue":"35","key":"10.6061\/clinics\/2018\/e473s_bib90","doi-asserted-by":"crossref","first-page":"20961","DOI":"10.1016\/S0021-9258(19)30030-4","article-title":"Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta)","volume":"264","author":"Mornet","year":"1989","journal-title":"J Biol Chem"},{"key":"10.6061\/clinics\/2018\/e473s_bib91","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jsbmb.2015.05.013","article-title":"The next 150 years of congenital adrenal hyperplasia","volume":"153","author":"Turcu","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib92","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/geno.1999.5459","article-title":"Cloning, expression, and physical mapping of the 3beta-hydroxysteroid dehydrogenase gene cluster (HSD3BP1-HSD3BP5) in human","volume":"61","author":"McBride","year":"1999","journal-title":"Genomics"},{"issue":"8","key":"10.6061\/clinics\/2018\/e473s_bib93","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1210\/mend-5-8-1147","article-title":"Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase\/delta 5-delta 4-isomerase in human adrenals and gonads","volume":"5","author":"Rh\u00e9aume","year":"1991","journal-title":"Mol Endocrinol"},{"issue":"4","key":"10.6061\/clinics\/2018\/e473s_bib94","first-page":"1678","article-title":"Characterization of two novel homozygous missense mutations involving codon 6 and 259 of type II 3beta-hydroxysteroid dehydrogenase (3betaHSD) gene causing, respectively, nonsalt-wasting and salt-wasting 3betaHSD deficiency disorder","volume":"85","author":"Zhang","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib95","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1210\/jcem-63-3-789","article-title":"Assignment of the gene for adrenal P450c17 (steroid 17 alpha hydroxylase\/17,20 lyase) to human chromosome 10","volume":"63","author":"Matteson","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib96","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1210\/jc.2003-031021","article-title":"Brazilian Congenital Adrenal Hyperplasia Multicenter Study Group Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency","volume":"89","author":"Costa-Santos","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.6061\/clinics\/2018\/e473s_bib97","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1086\/429417","article-title":"Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis","volume":"76","author":"Huang","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.6061\/clinics\/2018\/e473s_bib98","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/jcem-24-10-947","article-title":"Cushing\u2019s syndrome: nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor","volume":"24","author":"Kischiner","year":"1964","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.6061\/clinics\/2018\/e473s_bib99","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.beem.2008.10.011","article-title":"ACTH-independent macronodular adrenal hyperplasia","volume":"23","author":"Lacroix","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2018\/e473s_bib100","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1749-6632.2002.tb04339.x","article-title":"Cyclic AMP-dependent signaling aberrations in macronodular adrenal disease","volume":"968","author":"Bourdeau","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib101","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/JOE-14-0568","article-title":"Genetics of primary macronodular adrenal hyperplasia","volume":"224","author":"Fragoso","year":"2015","journal-title":"J Endocrinol"},{"issue":"22","key":"10.6061\/clinics\/2018\/e473s_bib102","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1056\/NEJMoa1215245","article-title":"Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia","volume":"369","author":"Louiset","year":"2013","journal-title":"N Engl J Med"},{"key":"10.6061\/clinics\/2018\/e473s_bib103","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2017.06.027","article-title":"The role of ARMC5 in human cell cultures from nodules of primary macronodular adrenocortical hyperplasia (PMAH)","volume":"460","author":"Cavalcante","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"22","key":"10.6061\/clinics\/2018\/e473s_bib104","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing\u2019s syndrome","volume":"369","author":"Assi\u00e9","year":"2013","journal-title":"N Engl J Med"},{"issue":"8","key":"10.6061\/clinics\/2018\/e473s_bib105","doi-asserted-by":"crossref","first-page":"E1501","DOI":"10.1210\/jc.2013-4237","article-title":"ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia","volume":"99","author":"Alencar","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.6061\/clinics\/2018\/e473s_bib106","doi-asserted-by":"crossref","first-page":"E1113","DOI":"10.1210\/jc.2013-4280","article-title":"Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation","volume":"99","author":"Faucz","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.6061\/clinics\/2018\/e473s_bib107","doi-asserted-by":"crossref","first-page":"E1784","DOI":"10.1210\/jc.2014-1265","article-title":"ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia","volume":"99","author":"Gagliardi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.6061\/clinics\/2018\/e473s_bib108","doi-asserted-by":"crossref","first-page":"E926","DOI":"10.1210\/jc.2014-4204","article-title":"ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences","volume":"100","author":"Espiard","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2018\/e473s_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13834","article-title":"Armc5 deletion causes developmental defects and compromises T-cell immune responses","volume":"8","author":"Hu","year":"2017","journal-title":"Nat Commun"},{"issue":"18","key":"10.6061\/clinics\/2018\/e473s_bib110","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1093\/hmg\/ddx235","article-title":"Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function","volume":"26","author":"Berthon","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.6061\/clinics\/2018\/e473s_bib111","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.beem.2011.12.006","article-title":"Adrenal incidentaloma","volume":"26","author":"Arnaldi","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2018\/e473s_bib112","first-page":"161","article-title":"Cushing\u2019s syndrome","volume":"6","author":"Nieman","year":"1997","journal-title":"Curr Ther Endocrinol Metab"},{"issue":"12","key":"10.6061\/clinics\/2018\/e473s_bib113","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1210\/en.2004-0900","article-title":"Minireview: PRKAR1A: normal and abnormal functions","volume":"145","author":"Bossis","year":"2004","journal-title":"Endocrinology"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib114","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mce.2011.10.006","article-title":"The cAMP pathway and the control of adrenocortical development and growth","volume":"351","author":"de Joussineau","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"10.6061\/clinics\/2018\/e473s_bib115","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal Cushing\u2019s syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N Engl J Med"},{"issue":"6186","key":"10.6061\/clinics\/2018\/e473s_bib116","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1126\/science.1252328","article-title":"Recurrent somatic mutations underlie corticotropin-independent Cushing\u2019s syndrome","volume":"344","author":"Sato","year":"2014","journal-title":"Science"},{"issue":"4","key":"10.6061\/clinics\/2018\/e473s_bib117","doi-asserted-by":"crossref","first-page":"M99","DOI":"10.1530\/EJE-15-0353","article-title":"cAMP signaling in cortisol-producing adrenal adenoma","volume":"173","author":"Calebiro","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"9996","key":"10.6061\/clinics\/2018\/e473s_bib118","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing\u2019s syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"24","key":"10.6061\/clinics\/2018\/e473s_bib119","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","article-title":"Activating mutations of the stimulatory G protein in the McCune-Albright syndrome","volume":"325","author":"Weinstein","year":"1991","journal-title":"N Engl J Med"},{"issue":"4","key":"10.6061\/clinics\/2018\/e473s_bib120","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet"},{"issue":"1-2","key":"10.6061\/clinics\/2018\/e473s_bib121","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.mce.2013.01.018","article-title":"KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling","volume":"371","author":"Boulkroun","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.6061\/clinics\/2018\/e473s_bib122","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","article-title":"Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma","volume":"64","author":"Fernandes-Rosa","year":"2014","journal-title":"Hypertension"},{"issue":"2","key":"10.6061\/clinics\/2018\/e473s_bib123","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.111.183996","article-title":"KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism","volume":"59","author":"Mulatero","year":"2012","journal-title":"Hypertension"},{"issue":"4","key":"10.6061\/clinics\/2018\/e473s_bib124","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W","article-title":"Adrenocortical carcinoma: clinical and laboratory observations","volume":"88","author":"Wajchenberg","year":"2000","journal-title":"Cancer"},{"issue":"11","key":"10.6061\/clinics\/2018\/e473s_bib125","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/1097-0142(19931201)72:11<3145::AID-CNCR2820721105>3.0.CO;2-N","article-title":"Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature","volume":"72","author":"Wooten","year":"1993","journal-title":"Cancer"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib126","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1677\/erc.1.01029","article-title":"Management of patients with adrenal cancer: recommendations of an international consensus conference","volume":"12","author":"Schteingart","year":"2005","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2012.04403.x","article-title":"Genetic aspects of adrenocortical tumours and hyperplasias","volume":"77","author":"Mazzuco","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.6061\/clinics\/2018\/e473s_bib128","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/jso.23112","article-title":"Adrenocortical carcinoma: past, present, and future","volume":"106","author":"Lafemina","year":"2012","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.6061\/clinics\/2018\/e473s_bib129","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors","volume":"8","author":"Weiss","year":"1980","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.6061\/clinics\/2018\/e473s_bib131","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.humpath.2009.03.010","article-title":"The Weiss system for evaluating adrenocortical neoplasms: 25 years later","volume":"40","author":"Lau","year":"2009","journal-title":"Hum Pathol"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib132","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1590\/2359-3997000000274","article-title":"Diagnosis and management of primary aldosteronism","volume":"61","author":"Vilela","year":"2017","journal-title":"Arch Endocrinol Metab"},{"issue":"6","key":"10.6061\/clinics\/2018\/e473s_bib133","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/joim.12452","article-title":"Genetics of adrenocortical tumours","volume":"280","author":"\u00c5kerstr\u00f6m","year":"2016","journal-title":"J Intern Med"},{"issue":"6","key":"10.6061\/clinics\/2018\/e473s_bib134","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"Clinical practice. The incidentally discovered adrenal mass","volume":"356","author":"Young","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.6061\/clinics\/2018\/e473s_bib135","first-page":"656","article-title":"Steroid profile in urine: a useful tool in the diagnosis and follow up of adrenocortical carcinoma","volume":"122","author":"Gr\u00f6ndal","year":"1990","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"6","key":"10.6061\/clinics\/2018\/e473s_bib136","doi-asserted-by":"crossref","first-page":"R325","DOI":"10.1530\/ERC-15-0318","article-title":"Developing treatment for adrenocortical carcinoma","volume":"22","author":"Kerkhofs","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"10.6061\/clinics\/2018\/e473s_bib137","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/cncr.23886","article-title":"Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors","volume":"113","author":"Bilimoria","year":"2008","journal-title":"Cancer"},{"issue":"5","key":"10.6061\/clinics\/2018\/e473s_bib138","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jviscsurg.2017.06.010","article-title":"Surgical treatment of adrenal carcinoma","volume":"154","author":"Gaujoux","year":"2017","journal-title":"J Visc Surg"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib139","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mce.2011.09.042","article-title":"Insulin-like growth factor system on adrenocortical tumorigenesis","volume":"351","author":"Ribeiro","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"10.6061\/clinics\/2018\/e473s_bib140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103744","article-title":"IGF2 promotes growth of adrenocortical carcinoma cells, but its overexpression does not modify phenotypic and molecular features of adrenocortical carcinoma","volume":"9","author":"Guillaud-Bataille","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib141","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/jso.24665","article-title":"Diagnostic and prognostic role of SF1, IGF2, Ki67, p53, adiponectin, and leptin receptors in human adrenal cortical tumors","volume":"116","author":"Babi\u0144ska","year":"2017","journal-title":"J Surg Oncol"},{"issue":"9","key":"10.6061\/clinics\/2018\/e473s_bib142","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1210\/jc.2008-0065","article-title":"Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors","volume":"93","author":"Almeida","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib143","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1210\/jc.2008-1456","article-title":"Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma","volume":"94","author":"Barlaskar","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.6061\/clinics\/2018\/e473s_bib144","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1530\/ERC-16-0266","article-title":"Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas","volume":"23","author":"Creemers","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"12","key":"10.6061\/clinics\/2018\/e473s_bib145","first-page":"3503","article-title":"beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer","volume":"62","author":"Clements","year":"2002","journal-title":"Cancer Res"},{"issue":"9","key":"10.6061\/clinics\/2018\/e473s_bib146","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1158\/1535-7163.MCT-17-0139","article-title":"Wnt\/\u03b2-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor","volume":"16","author":"Zeng","year":"2017","journal-title":"Mol Cancer Ther"},{"issue":"15","key":"10.6061\/clinics\/2018\/e473s_bib147","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1158\/0008-5472.CAN-17-0202","article-title":"\u03b2-Catenin Is a Candidate Therapeutic Target for Myeloid Neoplasms with del(5q)","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res"},{"issue":"4","key":"10.6061\/clinics\/2018\/e473s_bib148","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1055\/s-0037-1601320","article-title":"Pathogenetic Analysis of Sinonasal Teratocarcinosarcomas Reveal Actionable \u03b2-catenin Overexpression and a \u03b2-catenin Mutation","volume":"78","author":"Birkeland","year":"2017","journal-title":"J Neurol Surg B Skull Base"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib149","first-page":"286","article-title":"Ovarian cancer in endometriosis: an update on the clinical and molecular aspects","volume":"69","author":"Ruderman","year":"2017","journal-title":"Minerva Ginecol"},{"issue":"17","key":"10.6061\/clinics\/2018\/e473s_bib150","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","article-title":"Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors","volume":"65","author":"Tissier","year":"2005","journal-title":"Cancer Res"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib151","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ajpath.2012.05.026","article-title":"Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and \u03b2-catenin","volume":"181","author":"Heaton","year":"2012","journal-title":"Am J Pathol"},{"issue":"10","key":"10.6061\/clinics\/2018\/e473s_bib152","doi-asserted-by":"crossref","first-page":"13545","DOI":"10.1007\/s13277-016-5257-x","article-title":"Investigation of N-cadherin\/\u03b2-catenin expression in adrenocortical tumors","volume":"37","author":"Rubin","year":"2016","journal-title":"Tumour Biol"},{"issue":"40","key":"10.6061\/clinics\/2018\/e473s_bib153","doi-asserted-by":"crossref","first-page":"43016","DOI":"10.18632\/oncotarget.5513","article-title":"Inhibition of the Tcf\/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis","volume":"6","author":"Leal","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.6061\/clinics\/2018\/e473s_bib154","doi-asserted-by":"crossref","first-page":"R249","DOI":"10.1530\/EJE-15-1118","article-title":"Endocrine tumours: The genomics of adrenocortical tumors","volume":"174","author":"Faillot","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.6061\/clinics\/2018\/e473s_bib155","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat Genet"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib156","doi-asserted-by":"crossref","first-page":"E493","DOI":"10.1210\/jc.2014-3282","article-title":"Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma","volume":"100","author":"Juhlin","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.6061\/clinics\/2018\/e473s_bib157","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Characterization of Adrenocortical Carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"issue":"10","key":"10.6061\/clinics\/2018\/e473s_bib158","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1210\/jcem.86.10.7957","article-title":"An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors","volume":"86","author":"Latronico","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"10.6061\/clinics\/2018\/e473s_bib159","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1200\/JCO.2009.27.5958","article-title":"Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel","volume":"28","author":"Berruti","year":"2010","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.6061\/clinics\/2018\/e473s_bib160","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/annonc\/mdv329","article-title":"Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study","volume":"26","author":"Lib\u00e9","year":"2015","journal-title":"Ann Oncol"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib161","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12672-015-0242-1","article-title":"5th International ACC Symposium: Classification of Adrenocortical Cancers from Pathology to Integrated Genomics: Real Advances or Lost in Translation?","volume":"7","author":"de Krijger","year":"2016","journal-title":"Horm Cancer"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib162","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2014-3182","article-title":"Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection","volume":"100","author":"Beuschlein","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib163","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1210\/jc.2009-2040","article-title":"Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults","volume":"95","author":"Almeida","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.6061\/clinics\/2018\/e473s_bib164","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1210\/mend.12.5.0100","article-title":"The basic helix-loop-helix, leucine zipper transcription factor, USF (upstream stimulatory factor), is a key regulator of SF-1 (steroidogenic factor-1) gene expression in pituitary gonadotrope and steroidogenic cells","volume":"12","author":"Harris","year":"1998","journal-title":"Mol Endocrinol"},{"issue":"16","key":"10.6061\/clinics\/2018\/e473s_bib165","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1242\/dev.01266","article-title":"Disrupted gonadogenesis and male-to-female sex reversal in Pod1 knockout mice","volume":"131","author":"Cui","year":"2004","journal-title":"Development"},{"issue":"2","key":"10.6061\/clinics\/2018\/e473s_bib166","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1158\/1078-0432.CCR-08-1067","article-title":"Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling","volume":"15","author":"Giordano","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.6061\/clinics\/2018\/e473s_bib167","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/gcc.21978","article-title":"Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors","volume":"51","author":"Fonseca","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"10.6061\/clinics\/2018\/e473s_bib168","doi-asserted-by":"crossref","first-page":"E1004","DOI":"10.1210\/jc.2011-3298","article-title":"DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors","volume":"97","author":"Rechache","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2018\/e473s_bib169","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mce.2017.08.009","article-title":"Epigenetic dysregulation in adrenocortical carcinoma, a systematic review of the literature","volume":"469","author":"Jonker","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"10.6061\/clinics\/2018\/e473s_bib170","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1158\/0008-5472.CAN-05-0298","article-title":"MicroRNA biogenesis and cancer","volume":"65","author":"Gregory","year":"2005","journal-title":"Cancer Res"},{"key":"10.6061\/clinics\/2018\/e473s_bib171","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fendo.2015.00195","article-title":"microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges","volume":"6","author":"Cherradi","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.6061\/clinics\/2018\/e473s_bib172","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2016.12.011","article-title":"The role of microRNAs in the pathophysiology of adrenal tumors","volume":"456","author":"Hassan","year":"2017","journal-title":"Mol Cell Endocrinol"},{"issue":"24","key":"10.6061\/clinics\/2018\/e473s_bib173","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.1158\/1078-0432.CCR-09-1587","article-title":"miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer","volume":"15","author":"Soon","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.6061\/clinics\/2018\/e473s_bib174","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1530\/ERC-13-0051","article-title":"Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients","volume":"20","author":"Chabre","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.6061\/clinics\/2018\/e473s_bib175","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.surg.2013.06.022","article-title":"MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors","volume":"154","author":"Patel","year":"2013","journal-title":"Surgery"},{"issue":"39","key":"10.6061\/clinics\/2018\/e473s_bib176","doi-asserted-by":"crossref","first-page":"65525","DOI":"10.18632\/oncotarget.19118","article-title":"New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer","volume":"8","author":"Salvianti","year":"2017","journal-title":"Oncotarget"},{"issue":"30","key":"10.6061\/clinics\/2018\/e473s_bib177","doi-asserted-by":"crossref","first-page":"49191","DOI":"10.18632\/oncotarget.16788","article-title":"Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy","volume":"8","author":"Koperski","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.6061\/clinics\/2018\/e473s_bib178","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1530\/ERC-11-0082","article-title":"The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma","volume":"18","author":"\u00d6zata","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"10.6061\/clinics\/2018\/e473s_bib179","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/cncr.25724","article-title":"MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy","volume":"117","author":"Patterson","year":"2011","journal-title":"Cancer"},{"issue":"6","key":"10.6061\/clinics\/2018\/e473s_bib180","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/jcp.2010.085621","article-title":"Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours","volume":"64","author":"Schmitz","year":"2011","journal-title":"J Clin Pathol"},{"issue":"9","key":"10.6061\/clinics\/2018\/e473s_bib181","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1101\/gr.132159.111","article-title":"The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression","volume":"22","author":"Derrien","year":"2012","journal-title":"Genome Res"},{"issue":"6","key":"10.6061\/clinics\/2018\/e473s_bib182","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrg3722","article-title":"The rise of regulatory RNA","volume":"15","author":"Morris","year":"2014","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib183","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/ERC-14-0457","article-title":"Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence","volume":"22","author":"Glover","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib184","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000478-198903000-00004","article-title":"Pathologic features of prognostic significance in adrenocortical carcinoma","volume":"13","author":"Weiss","year":"1989","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.6061\/clinics\/2018\/e473s_bib185","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00000478-200307000-00001","article-title":"Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients","volume":"27","author":"Wieneke","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.6061\/clinics\/2018\/e473s_bib186","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1200\/JCO.2004.08.085","article-title":"Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry","volume":"22","author":"Michalkiewicz","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.6061\/clinics\/2018\/e473s_bib187","first-page":"223","article-title":"[Familial malformation complex with umbilical hernia and Macroglossia-a \u201cnew syndrome\u201d?]","volume":"13","author":"Wiedemann","year":"1964","journal-title":"J Genet Hum"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib188","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ejhg.2009.106","article-title":"Beckwith-Wiedemann syndrome","volume":"18","author":"Weksberg","year":"2010","journal-title":"Eur J Hum Genet"},{"issue":"18","key":"10.6061\/clinics\/2018\/e473s_bib189","first-page":"5358","article-title":"A cancer family syndrome in twenty-four kindreds","volume":"48","author":"Li","year":"1988","journal-title":"Cancer Res"},{"issue":"5","key":"10.6061\/clinics\/2018\/e473s_bib190","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrclinonc.2014.41","article-title":"Li-Fraumeni syndrome: cancer risk assessment and clinical management","volume":"11","author":"McBride","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"issue":"Spec No 1","key":"10.6061\/clinics\/2018\/e473s_bib191","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1093\/hmg\/ddg067","article-title":"Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development","volume":"12","author":"Weksberg","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.6061\/clinics\/2018\/e473s_bib192","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7302","article-title":"Genomic landscape of paediatric adrenocortical tumours","volume":"6","author":"Pinto","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib193","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mce.2011.10.019","article-title":"Molecular epidemiology of adrenocortical tumors in southern Brazil","volume":"351","author":"Cust\u00f3dio","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"16","key":"10.6061\/clinics\/2018\/e473s_bib194","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1073\/pnas.161479898","article-title":"An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma","volume":"98","author":"Ribeiro","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.6061\/clinics\/2018\/e473s_bib195","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1590\/S0004-27302004000500009","article-title":"Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors","volume":"48","author":"Pinto","year":"2004","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"6653","key":"10.6061\/clinics\/2018\/e473s_bib196","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/39797","article-title":"Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome","volume":"389","author":"Sun","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib197","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ajpath.2012.05.026","article-title":"Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and \u03b2-catenin","volume":"181","author":"Heaton","year":"2012","journal-title":"Am J Pathol"},{"issue":"6","key":"10.6061\/clinics\/2018\/e473s_bib198","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1677\/JME-09-0143","article-title":"Adrenocortical development and cancer: focus on SF-1","volume":"44","author":"Lalli","year":"2010","journal-title":"J Mol Endocrinol"},{"issue":"8","key":"10.6061\/clinics\/2018\/e473s_bib199","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ejca.2006.01.022","article-title":"SF-1 overexpression in childhood adrenocortical tumours","volume":"42","author":"Pianovski","year":"2006","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.6061\/clinics\/2018\/e473s_bib200","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1210\/jc.2009-2040","article-title":"Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults","volume":"95","author":"Almeida","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2018\/e473s_bib201","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jsbmb.2016.02.031","article-title":"Combined steroidogenic characters of fetal adrenal and Leydig cells in childhood adrenocortical carcinoma","volume":"159","author":"Fujisawa","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"8","key":"10.6061\/clinics\/2018\/e473s_bib202","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1210\/jc.2007-0342","article-title":"Nephroblastoma overexpressed\/cysteine-rich protein 61\/connective tissue growth factor\/nephroblastoma overexpressed gene-3 (NOV\/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors","volume":"92","author":"Doghman","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.6061\/clinics\/2018\/e473s_bib203","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1158\/0008-5472.CAN-09-3970","article-title":"Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors","volume":"70","author":"Doghman","year":"2010","journal-title":"Cancer Res"},{"issue":"9","key":"10.6061\/clinics\/2018\/e473s_bib204","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1210\/jc.2008-0065","article-title":"Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors","volume":"93","author":"Almeida","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.6061\/clinics\/2018\/e473s_bib205","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1210\/jc.2008-1456","article-title":"Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma","volume":"94","author":"Barlaskar","year":"2009","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222011231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222011231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:00:34Z","timestamp":1761721234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222011231"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1807-59322018000200316&lng=en&nrm=iso&tlng=en","label":"SCIELO"},{"URL":"https:\/\/www.clinicsjournal.com\/article\/the-human-adrenal-cortex-growth-control-and-disorders\/","label":"CLINICS"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":205,"alternative-id":["S1807593222011231"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2018\/e473s","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The human adrenal cortex: growth control and disorders","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2018\/e473s","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}],"article-number":"e473s"}}